A Long-term Study of DE-117 Ophthalmic Solution Monotherapy and Concomitant Use of DE-117 Ophthalmic Solution With Timolol Ophthalmic Solution in Patients With OAG or OH: RENGE Study
PHASE3CompletedINTERVENTIONAL
Enrollment
125
Participants
Timeline
Start Date
July 1, 2016
Primary Completion Date
November 9, 2017
Study Completion Date
November 9, 2017
Conditions
Open Angle Glaucoma or Ocular Hypertension
Interventions
DRUG
DE-117 ophthalmic solution
DRUG
Timolol ophthalmic solution
Trial Locations (1)
Unknown
Tokyo
All Listed Sponsors
lead
Santen Pharmaceutical Co., Ltd.
INDUSTRY
NCT02822729 - A Long-term Study of DE-117 Ophthalmic Solution Monotherapy and Concomitant Use of DE-117 Ophthalmic Solution With Timolol Ophthalmic Solution in Patients With OAG or OH: RENGE Study | Biotech Hunter | Biotech Hunter